Pretreatment with intravenous FGF-13 reduces infarct volume and ameliorates neurological deficits following focal cerebral ischemia in rats

Brain Research

Volumn 818, Issue 1, 1999, Pages 140-146

  Yao, Da Lin ^a   Masonic, Kelly ^a   Petullo, David ^a   Ling Li, Yu ^a   Lincoln, Clint ^a   Wibberley, Lizbeth ^a   Alderson, Ralph F ^a   Antonaccio, Michael ^a  

^a Hum Genome Sci 9410 Key W Avenue ^*  (United States)

Author keywords

Cerebral infarction; Fibroblast growth factor 13; Focal cerebral ischemia

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN SIZE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; MODEL; MOLECULAR CLONING; NERVOUS TISSUE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CEREBRAL INFARCTION; FIBROBLAST GROWTH FACTORS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISCHEMIC ATTACK, TRANSIENT; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033528235     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01118-4     Document Type: Article

References (23)

1. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
2. Bodsch W., Barbier A., Oehmichen M., Grosse O.B., Hossman K.A. Recovery of monkey brain after prolonged ischemia: II. Protein synthesis and morphological alteration. Cereb. Blood Flow Metab. 6:1986;22-33.
3. Fisher M., Meadows M.E., Do T., Weise J., Trubetskoy V., Charette M., Finklestein S.P. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;953-959.
4. Ginsberg M.D., Pulsinelli W.A. The ischemic penumbra injury thresholds, and the therapeutic window for acute stroke. Ann. Neurol. 36:1994;553-554.
5. Green J.M., Li Y.L., Yourey P.A., Gruber J., Carter K.C., Shell B.K., Dillion P.A., Florence C., Duan D.R., Blunt A., Ornitz D.M., Ruben S.M., Alderson R.F. Identification and characterization of a novel member of the fibroblast growth factor family. Eur. J. Neurosci. 10:1998;1911-1925.
6. Hossmann K.A. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36:1994;557-565.
7. Jiang N., Finklestein S.P., Do T., Caday C.G., Charette M., Chopp M. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J. Neurol. Sci. 139:1996;173-179.
8. Kawamata T., Alexis N.E., Dietrich W.D., Finklestein S.P. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J. Cereb. Blood Flow Metab. 16:1996;542-547.
9. Kirino T., Tamura A., Sano K. Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol. 64:1984;139-147.
10. Koketsu N., Berlove D.J., Moscowitz M.A., Kowall N.W., Caday C.G., Finklestein S.P. Pretreatment with intraventricular basic fibroblast growth factor (bFGF) decreases infarct size following focal cerebral ischemia in rats. Ann. Neurol. 35:1994;451-457.
11. Koroshetz W.J., Moskowitz M.A. Emerging treatments for stroke in humans. Trends Pharmacol. Sci. 17:1996;227-233.
12. Linnik M.D., Zobrist R.H., Hatfield M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 24:1993;2002-2008.
13. Lowenstein D.H., Chan P.H., Miles M.F. The stress protein response in cultured neurons: characterization and evidence for a protective role in excitotoxicity. Neuron. 7:1991;1053-1060.
14. M.P. Mattson, S.W. Barger, Programmed cell life: neuroprotective signal transduction and ischemic brain injury, in: M.A. Moskowitz, L.R. Caplan (Eds.), Cerebrovascular Diseases: The 19th Princeton Stroke Conference, Butterworth Heinemann, Newton, MA, 1995, pp. 271-290.
15. 2+ extrusion in protection against neuronal excitotoxicity. FASEB J. 3:1989;2519-2526.
16. Mattson M.P., Scheff S.W. Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma. 11:1994;3-33.
17. National Research Council, Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animals Resource, National Academy Press, Washington, DC, 1966.
18. Petito C.K., Feldman E., Pulsinelli W.A., Plum F. Delayed hippocampal damage in humans following cardiorepiratory arrest. Neurology. 37:1987;1281-1286.
19. Rordorf G., Koroshetz W.J., Bonaventre J.V. Heat shock protects cultured neurons from glutamate toxicity. Neuron. 7:1991;1043-1051.
20. Rosenblatt S., Irikura K., Caday C.G., Finklestein S.P., Moskowitz M.A. Basic fibroblast growth factor (bFGF) dilates rat pial arterioles. J. Cereb. Blood Flow Metab. 14:1994;70-74.
21. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1:1981;53-60.
22. Tatter S., Galpern W.R., Isacson O. Neurotrophic factor protection against excitotoxic neuronal death. Neuroscientist. 1:1995;286-297.
23. Walicke P.A. Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J. Neurosci. 8:1988;2618-2627.